Matrix MetalloproteinasesNovel Targets for Directed Cancer Therapy

被引：0
|
作者：
Anita E. Yu
Robert E. Hewitt
Edward W. Connor
William G. Stetler-Stevenson
机构：
[1] National Cancer Institute,Laboratory of Pathology
[2] National Institutes of Health,Extracellular Matrix Pathology Section, Laboratory of Pathology
[3] DCS/NCI/NIH,undefined
来源：
Drugs & Aging | 1997年 / 11卷
关键词：
Adis International Limited; Collagenase; Tissue Inhibitor; Human Amniotic Membrane; Matrix Metalloproteinase Inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Matrix metalloproteinases (MMPs), or matrixins, are a family of zinc endopeptidases that play a key role in both physiological and pathological tissue degradation. Normally, there is a careful balance between cell division, matrix synthesis and matrix degradation, which is under the control of cytokines, growth factors and cell matrix interactions. The MMPs are involved in remodelling during tissue morphogenesis and wound healing.
引用
收藏
页码：229 / 244
页数：15
相关论文
共 50 条
  • [1] Matrix metalloproteinases - Novel targets for directed cancer therapy
    Yu, AE
    Hewitt, RE
    Connor, EW
    StetlerStevenson, WG
    DRUGS & AGING, 1997, 11 (03) : 229 - 244
  • [2] Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
    Christopher M. Overall
    Oded Kleifeld
    Nature Reviews Cancer, 2006, 6 : 227 - 239
  • [3] Matrix metalloproteinases in cancer: Prognostic markers and targets for therapy (Review)
    Duffy, MJ
    McCarthy, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (06) : 1343 - 1348
  • [4] Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
    Overall, CM
    Kleifeld, O
    NATURE REVIEWS CANCER, 2006, 6 (03) : 227 - 239
  • [5] Are autoantibodies the targets of B-cell-directed therapy?
    David S. Pisetsky
    Amrie C. Grammer
    Tony C. Ning
    Peter E. Lipsky
    Nature Reviews Rheumatology, 2011, 7 : 551 - 556
  • [6] Matrix metalloproteinases as therapeutic targets in cancer
    Vihinen, P
    Ala-aho, R
    Kähäri, VM
    CURRENT CANCER DRUG TARGETS, 2005, 5 (03) : 203 - 220
  • [7] Matrix metalloproteinase proteomics: substrates, targets, and therapy
    Morrison, Charlotte J.
    Butler, Georgina S.
    Rodriguez, David
    Overall, Christopher M.
    CURRENT OPINION IN CELL BIOLOGY, 2009, 21 (05) : 645 - 653
  • [8] Matrix metalloproteinases as targets for therapy in Kaposi sarcoma
    Fingleton, B
    Matrisian, LM
    CURRENT OPINION IN ONCOLOGY, 2001, 13 (05) : 368 - 373
  • [9] Molecular targets in cancer therapy
    Kummar, Shivaani
    Doroshow, James H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (03) : 267 - 269
  • [10] Novel Targets in Cancer Therapy
    Banerjee, Debabrata
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2009, 10 (02) : 147 - 147
12345